Investing Profile

Graeme R. Martin

InvestorVC

Chief Investment Officer at ALSA Ventures

alsaventures.comSan Francisco Bay Area

‌

‌

‌

Your Intro Paths to Graeme R. Martin

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

Find Graeme R. Martin on

cb

Current Investing Position

ALSA Ventures Investor

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

12

Graeme R. Martin is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)Chemicals (Seed)San Francisco Bay Area Pharmaceuticals (Pre-seed)Chemicals (Pre-seed)BioTech (Pre-seed)

Graeme R. Martin's Investments On Record (9)

Company	StageDateRound Size	Total Raised
Univercells	Series UnknownOct 2015$3M	$3M
Presage Biosciences	Series UnknownAug 2015
Co-investors: David Wu (Maveron)
Naurex	Series CDec 2014$80M Series AMay 2011$18M	$98M
Heptares Therapeutics	Series BJun 2013$21M	$21M
ArmaGen Technologies	Series ANov 2012$17M	$17M
Co-investors: Martin Heidecker (AMR Action Fund)
Redwood Bioscience	Series UnknownJun 2011
Serenex	Series DJun 2007$26M Series COct 2005$30M Series UnknownJul 2004$8M	$79M
Co-investors: Garheng Kong (HealthQuest Capital)
Lectus Therapeutics	Series AFeb 2006$14M	$14M
Co-investors: Antoine Papiernik Papiernik (Soffinova Partners)

Investors who invest with Graeme R. Martin